Imaging Biometrics Ltd. (LON:IBAI)
London · Delayed Price · Currency is GBP · Price in GBX 0.5250
0.00 (0.00%)
Mar 13, 2026, 3:34 PM GMT
Imaging Biometrics Market Cap
Imaging Biometrics has a market cap or net worth of 1.3 million as of March 13, 2026. Its market cap has decreased by -58.27% in one year.
Market Cap
1.30M
Enterprise Value
1.22M
Revenue
699.86K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
Market Cap Chart
Since June 16, 2017, Imaging Biometrics's market cap has decreased from 2.14M to 1.30M, a decrease of -39.36%. That is a compound annual growth rate of -5.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 1.30M | -38.24% |
| Dec 31, 2025 | 2.10M | -32.44% |
| Dec 31, 2024 | 3.10M | -65.36% |
| Dec 29, 2023 | 8.96M | 168.89% |
| Dec 30, 2022 | 3.33M | -69.56% |
| Dec 31, 2021 | 10.95M | -37.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 222.78B |
| GSK plc | 82.75B |
| Haleon | 32.63B |
| Smith & Nephew | 10.57B |
| N4 Pharma | 3.95M |
| Chill Brands Group | 2.75M |
| ValiRx | 2.27M |
| Roquefort Therapeutics | 1.68M |